Pregnant Women With Multidrug-Resistant/Rifampicin-Resistant Tuberculosis and the All-Oral 6-Month Regimen: Experiences From a Patient Series in South Africa
These limited data suggests that in pregnant women, the BDLLfx/BDLCfz regimens have improved treatment and pregnancy outcomes compared to prior regimens. However, there is a high prevalence of unfavourable infant outcomes.
Authors
- Richard Court (ORCID: https://orcid.org/0000-0002-7927-6506)
- Nalini Singh
- Jennifer Furin (ORCID: https://orcid.org/0000-0002-0825-7199)
- Sunitha Chotoo
- Sindisiwe Hlangu
- Marian Loveday (ORCID: https://orcid.org/0000-0001-9205-9314)
- Emma Clarence
- Catriona Waitt
- James C M Brust
Institutions
- South African Medical Research Council (ZA)
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
- University of Liverpool (GB)
- University of Cape Town (ZA)
- University Hospitals of Cleveland (US)
- Centre for the AIDS Programme of Research in South Africa (ZA)
- Liverpool Women's Hospital (GB)
- Infectious Diseases Institute (UG)
- King Edward VIII Hospital (ZA)
- Harvard Global Health Institute (US)
- Makerere University (UG)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1093/cid/ciag032
- Citations
- 1
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 32.78